Clinical Research Directory
Browse clinical research sites, groups, and studies.
Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant
Sponsor: University of Virginia
Summary
Chronic allograft rejection of the transplanted lung (CLAD) is a major health issue in patients after lung transplant. This study is a registry-forming study with concurrent tissue banking from surveillance bronchoscopy in addition to extra tissue sampling of blood and urine. Patients will be characterized by usual clinical phenotyping and the latest imaging methods so that diseased condition underlying CLAD can be better understood.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
1200
Start Date
2019-04-01
Completion Date
2038-12-31
Last Updated
2024-11-18
Healthy Volunteers
No
Conditions
Interventions
Lung transplant recipient without MRI imaging
Patients who received lung transplant and undergoing surveillance follow-up at 1, 3, 6, 12, 24 months after the date of lung transplant, but without consenting to be evaluated by hyperbolized gas MRI. Bronchoscopy sampling will be performed per usual lung transplant team protocol.
Lung transplant recipient with MRI imaging
Patients who received lung transplant and undergoing surveillance follow-up at 1, 3, 6, 12, 24 months after the date of lung transplant and with consenting to be evaluated by hyperbolized has MRI. Bronchoscopy sampling will be guided by the results of the hyper polarized gas MRI, different from the usual lung transplant team protocol. Administration of hyper polarized gas MRI is under FDA regulation by IND #129769 (PI, Yun Michael Shim, MD)
Locations (1)
University of Virginia Health System
Charlottesville, Virginia, United States